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Regenerative & Cellular Sciences 
An Interactive Workshop
EMBRYONIC STEM CELLS: ETHICS & ISSUES
RESPECTING / PROTECTING WOMEN
Women are central to embryonic stem cell research for they are the source of the primary 
tissue.  Whether the sourcing eggs for derivation of embryonic stem cells is leftover IVF 
embryos, egg-sharing schemes, or altruistic for-research donations, there are ethical 
issues with which women (and society) must grapple.
Given that women are often asked to donate embryos in the fertility treatment context, 
they are more likely to be vulnerable and could feel coerced.
Given that the embryonic material is needed for cell line derivation and future research, 
can informed consent ever truly be achieved?
Treating egg donation like blood or bone marrow donation supports women’s autonomous 
right to choose and make decisions for themselves, but can their consent be justified 
if the health risk is too high (or unknown – the full consequences of which are not well 
understood)?
‘… If you actually look at informed consent, there’s no such thing because you can 
never be fully informed because there’s always another question … .  … In a true sense 
… there is no such thing as informed consent.  [Rather] they’ve been given enough 
information that allows them to make a decision they’re comfortable with, I think.’ 
[UK Policy-Maker]
‘[A]fter the scandal … with Hwang … it was a great discussion in my 
group … [T]hey said if [she gave] informed consent, what was the 
problem, because if one doesn’t want [to do] something, then they 
shouldn’t do it.  [But] if it’s your chief asking you if you want to take 
part … it’s just always abuse of power.’ 
[Argentine Ethicist]
RESPECTING / PROTECTING EARLY LIFE
Embryonic stem cell research, more than any other type of stem cell 
research, raises important ethical and social issues relating to the beginning 
of (socially valuable) personhood and how to respect early life.
•	 Is the early embryo human life or a collection of cells?
•	 What makes human life valuable?
•	 Is using leftover IVF embryos a means of showing them respect 
because they will otherwise be discarded (which is disrespectful)?
•	 Is using embryos however obtained going too far down the 
instrumentalisation road?
‘In the broad sense … the discussion about the ethical use of embryos 
… goes to the very root of our experience as a society.  …  [W]hat’s 
life worth in the beginning?  How far can we go in manipulating that?   
The different religions [approach it differently].  It’s a very interesting 
discussion.’ 
[Argentine Researcher]
RESPECTING / PROTECTING PATIENTS
Patient safety is a key issue and many agree that much more basic research is required 
before most stem cell practices legitimately reach the clinical trial stage; premature clinical 
trials could set the whole field back (although some still think that the emphasis should be 
on disease-specific and translational research).
‘[U]sing these early cells, you don’t know what they might do … .  The dangers of viruses 
and other things in animal cells also another [risk].’ 
[UK Interfaith Group]
‘[Y]ou have got to make sure the [originators of the stem cell] are healthy … especially if 
they are taken early in life.  You have to monitor the person they came from to make sure 
nothing crops up later that would raise issues.’ [UK Clinical Stem Cell Scientist]
‘[Y]ou have to deal with safety concerns … .  You need clear-cut safety measures that have 
to be implemented … so we are not going to allow people to put things [in people].’ 
[Argentine Researcher]
The hype around stem cell research can make it difficult for scientists and can be harmful 
to the long-term future of the research by prompting people to take risks and sign up for 
dangerous trials:
‘I was reading something … about some scientists … that had just taken a load of 
embryonic stem cells and injected them into patients without doing proper controls or 
anything. … [S]ome people tend to think it is like a magical cure for everything, so go 
straight ahead with some things which a lot of preliminary work should [precede].’ 
[UK Stem Cell Scientist]
‘[Some people think] this is like a magic tree [and] that we are going to heal all diseases, 
which is [pure] fantasy … .  We don’t have even one patient who we can work with this 
technology and have to be extremely careful.’ [Argentine Researcher]
‘[I have concerns about] the tone of the discussion of stem cells within the public.  There 
must be a general statement to say this could be the future, but don’t put this in the everyday 
life of people because this creates a lot of uncertainty within patients which is absolutely 
unfair.’ [Argentine Researcher]
Research and new treatments must not be at the cost of public health.  Scientific funding is 
important but it should ideally be directed at objectives that can be delivered to populations 
and are not so expensive as to be restricted to elites.
‘[S]pending more money on research does not get the waiting list times down.’ 
[UK Stem Cell Scientist]
‘[D]oes money go into something that may initially help a few people or do you spend it on 
having someone’s blood pressure checked frequently and … treated well … ?’ 
[UK Nurse]
‘At present time it is only cost, there is no benefit.  In neurological diseases, this is just the 
future, and I think we are far from having this as a useful therapeutic option for patients.’ 
[Argentine Researcher] 
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